Inventor · Sudbury, MA, US

Robert Sackstein

20Patents
5h-index
9Co-inventors
62Inventor score

Filing activity: Oct 18, 2001 → Nov 10, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8084236B2 Compositions and methods for modifying cell surface glycans Chemistry; Metallurgy 11 Active
US7998740B2 Cytokine induction of selectin ligands on cells Chemistry; Metallurgy 9 Active
US7875585B2 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide Chemistry; Metallurgy 9 Expired
US7816500B2 Antibody SACK-1 that binds CD44 glycoforms Chemistry; Metallurgy 7 Active
US8728810B2 Methods for modifying cell surface glycans Chemistry; Metallurgy 5 Active
US8852935B2 Compositions and methods for modifying cell surface glycans Chemistry; Metallurgy 2 Active
US9523078B2 Method for increasing the E-selectin binding affinity of a population of cells expressing a CD44 polypeptide Chemistry; Metallurgy 2 Active
US9788539B2 Platelet protection solution having beta-galactosidase and sialidase inhibitors Human Necessities 1 Active
US7098195B2 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells Human Necessities 1 Expired
US9609861B2 Platelet additive solution having a β-galactosidase inhibitor Human Necessities 1 Active
US8633026B2 Cytokine induction of selectin ligands on cells Chemistry; Metallurgy 0 Active
US11939616B2 Compositions and methods for enforcing fucosylation of lactosaminyl glycans in human cells with alpha(1,3)-fucosyltransferases Chemistry; Metallurgy 0 Active
US11517580B2 Fucosyltransferase specific inhibition using fucose mimetics Chemistry; Metallurgy 0 Active
US12090173B2 Methods to improve cell therapy Chemistry; Metallurgy 0 Active
US8765126B2 Methods of treating complications and disorders associated with G-CSF administration Human Necessities 0 Active
US10271541B2 Platelet additive solution having a beta-galactosidase inhibitor Human Necessities 0 Active
US11535831B2 Compositions and methods for modifying cell surface glycans Chemistry; Metallurgy 0 Active
US10370642B2 Hematopoietic progenitor cell populations having affinity for E-selectin / L-selectin Chemistry; Metallurgy 0 Active
US9914913B2 Compositions and methods for modifying cell surface glycans Chemistry; Metallurgy 0 Active
US10471103B2 Methods to improve cell therapy Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.